Rounded atelectasis and respiratory compromise secondary to pergolide use
Chloe I Bloom1, Graeme E Wilson
1Hillingdon Hospital, Pield Heath, Uxbridge, UK. chloebloom@doctors.org.uk
Abstract:
Rounded atelectasis is an unusual form of peripheral atelectasis that develops as a consequence of pleural disease. It is usually thought to be a benign process after malignancy and infection have been excluded. Pergolide is an ergot-derived dopamine agonist that has been associated with pleuropulmonary fibrosis and fibrotic cardiac valve disease. Pergolide-associated rounded atelectasis has occurred in patients with known asbestos exposure. We report a patient with no known asbestos exposure who developed rounded atelectasis and subsequent symptomatic diffuse restrictive pleural disease. Physicians should consider drugs early on in their work-up of rounded atelectasis as discontinuation of the agent may reverse the process.
Related Concept Videos
Atelectasis II: Pathophysiology
Acute Respiratory Failure-III
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Pulmonary Cycle: Exhalation
Pneumothorax II: Pathophysiology
